139 related articles for article (PubMed ID: 4246091)
21. [Experience with Variotin in clinics, polyclinics and medical practice in Europe].
Rieth H
Mykosen; 1968 Jun; 11(6):471-4. PubMed ID: 4242214
[No Abstract] [Full Text] [Related]
22. [Experience with nizoral treatment of patients with rubromycosis].
Stepanova ZhV; Smol'iakova LL
Vestn Dermatol Venerol; 1988; (1):66-8. PubMed ID: 2966511
[No Abstract] [Full Text] [Related]
23. Evaluation of griseofulvin after four years.
DERBES VJ; FRIEDMAN L
J La State Med Soc; 1963 Aug; 115():276-80. PubMed ID: 14027097
[No Abstract] [Full Text] [Related]
24. [Experience with griseofulvin in the treatment of dermatomycoses and onychomycoses caused by dermatophytes of the Trichophyton group].
Kubec K
Cesk Dermatol; 1967 Feb; 42(1):36-9. PubMed ID: 4227336
[No Abstract] [Full Text] [Related]
25. GRISEOFULVIN IN DERMATOMYCOSIS.
BANERJEE AK; BASU N
Bull Calcutta Sch Trop Med; 1963 Jul; 11():116. PubMed ID: 14068665
[No Abstract] [Full Text] [Related]
26. [A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
Belukha UK; Bidrat MS; Luk'ianova AS
Vestn Dermatol Venerol; 1989; (1):50-2. PubMed ID: 2524142
[TBL] [Abstract][Full Text] [Related]
27. Long-term ketoconazole treatment of chronic acral dermatophyte infections.
Hersle K; Mobacken H; Moberg S
Int J Dermatol; 1985 May; 24(4):245-8. PubMed ID: 3159697
[TBL] [Abstract][Full Text] [Related]
28. [Fungal lesions of feet and hands in Alma-Ata].
Nemkaeva RM; Mulagulova GA; Morozova VA
Vestn Dermatol Venerol; 1975 Dec; (12):30-3. PubMed ID: 132805
[No Abstract] [Full Text] [Related]
29. COMPARATIVE EFFECTIVENESS OF GRISEOFULVIN DEPENDING ON CRYSTAL SIZE.
NIERMAN MM
Clin Med (Northfield); 1964 May; 71():823-8. PubMed ID: 15446158
[No Abstract] [Full Text] [Related]
30. TREATMENT OF FUNGUS INFECTIONS WITH MICROCRYSTALLINE GRISEOFULVIN.
MILLER WC
Clin Med (Northfield); 1963 Oct; 70():1837-40. PubMed ID: 15446067
[No Abstract] [Full Text] [Related]
31. Twenty years of griseofulvin therapy?
Mackman BJ
Arch Dermatol; 1980 Oct; 116(10):1100. PubMed ID: 7425652
[No Abstract] [Full Text] [Related]
32. [Clinical experience with 0.5% jaritin ointment and comparison of its effectiveness and tolerance with 1% haloprogin ointment (author's transl)].
Klima J
Cesk Dermatol; 1977 Oct; 52(5):319-23. PubMed ID: 146569
[No Abstract] [Full Text] [Related]
33. Haloprogin for tinea.
Med Lett Drugs Ther; 1973 Aug; 15(17):69-70. PubMed ID: 4740517
[No Abstract] [Full Text] [Related]
34. Griseofulvin and dysgeusia: implications?
Fogan L
Ann Intern Med; 1971 May; 74(5):795-6. PubMed ID: 5559448
[No Abstract] [Full Text] [Related]
35. [Terbinafine (Lamisil)].
Breton MC
Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
[No Abstract] [Full Text] [Related]
36. [Treatment of herpes zoster with griseofulvin].
Wolfram S
Dermatol Wochenschr; 1968 Apr; 154(17):385-7. PubMed ID: 5730767
[No Abstract] [Full Text] [Related]
37. [Griseofulvin in the treatment of herpes zoster].
Gwieździński Z; Protas-Drozd F
Przegl Dermatol; 1989; 76(1):45-9. PubMed ID: 2813817
[TBL] [Abstract][Full Text] [Related]
38. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
Faergemann J; Mörk NJ; Haglund A; Odegård T
Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of topical griseofulvin in treatment of tinea corporis.
Kassem MA; Esmat S; Bendas ER; El-Komy MH
Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
[TBL] [Abstract][Full Text] [Related]
40. [Epidermophytoses and Candida mycoses. Treatment and prevention of recurrence].
Meinhof W
Fortschr Med; 1974 Jun; 92(16):673-6. PubMed ID: 4835997
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
